BridgeMD
Compares treatment options for Primary Angle Closure Glaucoma
Official title Comparison of Phaco Surgery With Goniosynechialysis Versus Trabeculectomy in Glaucoma Treatment
ClinicalTrials.gov ID: NCT06952153
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether phacoemulsification combined with goniosynechialysis (Phaco-GSL) is as effective and safe as trabeculectomy in treating patients with primary angle-closure glaucoma. The main questions it aims to answer are: Does Phaco-GSL provide similar or better intraocular pressure (IOP) control compared to trabeculectomy?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Age ≥ 40 years
- Peripheral anterior synechiae (PAS) \>180°
- Glaucomatous optic neuropathy with visual field loss
- Intraocular pressure (IOP) \> 21 mmHg despite medication
- Ability to consent and comply with follow-up
You likely can't join if
- Very advanced glaucoma (only light perception vision)
- Secondary angle-closure etiologies
- Prior ocular surgeries or laser peripheral iridotomy (PI)
- Allergy to 5-fluorouracil (5-FU), if used postoperatively
- Irreversible corneal disease
- Chronic corticosteroid use
See the full eligibility criteria
- Age ≥ 40 years
- Peripheral anterior synechiae (PAS) \>180°
- Glaucomatous optic neuropathy with visual field loss
- Intraocular pressure (IOP) \> 21 mmHg despite medication
- Ability to consent and comply with follow-up
- Cataract grade 1 to 3 according to LOCS III
- Best corrected visual acuity (BCVA) ≥ 0.3 logMAR (equivalent to 20/40 Snellen or worse)
- Very advanced glaucoma (only light perception vision)
- Secondary angle-closure etiologies
- Prior ocular surgeries or laser peripheral iridotomy (PI)
- Allergy to 5-fluorouracil (5-FU), if used postoperatively
- Irreversible corneal disease
- Chronic corticosteroid use
- Poor follow-up compliance
- Cataract grade 4 or 5 (LOCS III)
- Phacomorphic, phacolytic, or subluxated cataracts
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.